Richard Kefford - Concepedia

Author

Richard Kefford

Also Known As

Andrew Spillane, Electron Kebebew, Georgina Long, Graham Mann, John Thompson, Kefford, Richard, Kenneth Lee, Lauren Haydu, Marat D. Kazanov, Maria Keays

613

Publications

102.3K

Citations

125

H-Index

192

Concepts

All Affiliations

The University of Sydney Westmead Hospital Melanoma Institute Australia Westmead Institute Macquarie University

About

Richard Kefford is an author at The University of Sydney specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	61	152	21.2K
2	Health Sciences	21	28	1.7K
3	Engineering	5	5	1.7K
4	Natural Sciences	5	5	225
5	Arts	1	1	188

Richard Kefford

290

Publications

55.8K

Citations

102

H-Index

Page 1

	Year	Citations
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma Omid Hamid, Caroline Robert, Adil Daud, New England Journal of Medicine	2013	3.4K
Genomic Classification of Cutaneous Melanoma Rehan Akbani, Kadir C. Akdemir, Bülent Arman Aksoy, Cell Dermoscopic ImageSkin CancerMedicineMelanomaPathology	2015	3.2K
Pan-cancer analysis of whole genomes Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Nature	2020	3.1K
Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations Keith T. Flaherty, J. Infante, Adil Daud, New England Journal of Medicine	2012	2.8K
Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib Jeffrey A. Sosman, Kevin B. Kim, Lynn M. Schuchter, New England Journal of Medicine	2012	2.1K
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial Caroline Robert, Antoni Ribas, Jedd D. Wolchok, The Lancet OncologyMedicineIpilimumab-refractory Advanced MelanomaImmunologyMelanoma	2014	1.7K
Whole-genome landscapes of major melanoma subtypes Nicholas K. Hayward, James S. Wilmott, Nicola Waddell, Nature Functional GenomicsSkin CancerTumor HeterogeneityMedicineGenetics	2017	1.4K
Adjuvant Dabrafenib plus Trametinib in Stage III<i>BRAF</i>-Mutated Melanoma Georgina V. Long, Axel Hauschild, Mario Santinami, New England Journal of Medicine	2017	1.4K
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma Antoni Ribas, Omid Hamid, Adil Daud, JAMA	2016	1K
Prognostic and Clinicopathologic Associations of Oncogenic <i>BRAF</i> in Metastatic Melanoma Georgina V. Long, Alexander M. Menzies, Adnan Nagrial, Journal of Clinical Oncology	2011	1K

Page 1